SKI Market

Indian Indices

Sensex

81,287.19 -961.42
( -1.17%)

Global Indices

Nasdaq

49,510.83 7.68
(0.02%)

Dow Jones

6,928.66 -38.47
(-0.55%)

Hang Seng

58,843.60 90.21
(0.15%)

Nikkei 225

10,847.75 41.34
(0.38%)

Forex

USD-INR

90.92 -0.01
(-0.01%)

EUR-INR

107.23 0.12
(0.12%)

GBP-INR

122.98 0.28
(0.22%)

JPY-INR

0.58 0.00
(-0.40%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gennex Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

531739

INE509C01026

8.6694335

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

17.87

269.19

EPS(TTM)

Face Value()

Div & Yield %

0.62

Back

Balkrishna Industries consolidated net profit declines 14.98% in the December 2025 quarter

Jan 29,2026

Net profit of Balkrishna Industries declined 14.98% to Rs 382.15 crore in the quarter ended December 2025 as against Rs 449.48 crore during the previous quarter ended December 2024. Sales rose 6.89% to Rs 2736.79 crore in the quarter ended December 2025 as against Rs 2560.33 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	2736.79	2560.33	7
OPM %	23.50	23.46	-
PBDT	686.40	772.27	-11
PBT	491.06	599.68	-18
NP	382.15	449.48	-15

81,287.19 -961.42 ( -1.17%)

49,510.83 7.68 (0.02%)

6,928.66 -38.47 (-0.55%)

58,843.60 90.21 (0.15%)

10,847.75 41.34 (0.38%)

90.92 -0.01 (-0.01%)

107.23 0.12 (0.12%)

122.98 0.28 (0.22%)

0.58 0.00 (-0.40%)